I find it incredible that we're already 3 weeks into January and there still hasn't been any news regarding financing....In my opinion a degree of the consternation being expressed over event rates and the time-line to get to 250 events (people suffering heart attacks and strokes) is exasperated by the lack of money in the bank....if the company had cash of $100 million in their coffers I know I would be somewhat more relaxed....however if the company was flush with do ré mi I doubt we'd be trading in the $3s, but that is a moot point at this stage.

The Third Eye loan included 3,500,000 warrants priced at $1.77 

https://www.resverlogix.com/investors/news?article=598

Exercising those warrants would cost just under $6.2 million and at $3.20 they'd be worth 11.2 million....that's about an 80% rate of return.  Is the company required to disclose if those warrants have been exercised?  I've been keeping an eye on canadianinsider.com and haven't seen anything since November 5th when a few thousand shares were issued in compensation for services:

https://www.canadianinsider.com/node/7?menu_tickersearch=RVX+%7C+Resverlogix